HEADER TRANSFERASE 04-SEP-20 7AAC TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PARP1 IN COMPLEX TITLE 2 WITH VELIPARIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN (662-1101); COMPND 5 SYNONYM: PARP-1,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 1,ARTD1, COMPND 6 DNA ADP-RIBOSYLTRANSFERASE PARP1,NAD(+) ADP-RIBOSYLTRANSFERASE 1, COMPND 7 ADPRT 1,POLY[ADP-RIBOSE] SYNTHASE 1,PROTEIN POLY-ADP- COMPND 8 RIBOSYLTRANSFERASE PARP1; COMPND 9 EC: 2.4.2.30,2.4.2.-; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP1, ADPRT, PPOL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: GOLD; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24A KEYWDS PARP INHIBITOR, PARYLATION, INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SCHIMPL,T.E.H.OGDEN,J.-C.YANG,L.E.EASTON,E.UNDERWOOD,P.B.RAWLINS, AUTHOR 2 J.W.JOHANNES,K.J.EMBREY,D.NEUHAUS REVDAT 4 01-MAY-24 7AAC 1 REMARK REVDAT 3 10-MAR-21 7AAC 1 JRNL REVDAT 2 10-FEB-21 7AAC 1 JRNL REVDAT 1 13-JAN-21 7AAC 0 JRNL AUTH T.E.H.OGDEN,J.C.YANG,M.SCHIMPL,L.E.EASTON,E.UNDERWOOD, JRNL AUTH 2 P.B.RAWLINS,M.M.MCCAULEY,M.F.LANGELIER,J.M.PASCAL, JRNL AUTH 3 K.J.EMBREY,D.NEUHAUS JRNL TITL DYNAMICS OF THE HD REGULATORY SUBDOMAIN OF PARP-1; SUBSTRATE JRNL TITL 2 ACCESS AND ALLOSTERY IN PARP ACTIVATION AND INHIBITION. JRNL REF NUCLEIC ACIDS RES. V. 49 2266 2021 JRNL REFN ESSN 1362-4962 JRNL PMID 33511412 JRNL DOI 10.1093/NAR/GKAB020 REMARK 2 REMARK 2 RESOLUTION. 1.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.59 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 68.6 REMARK 3 NUMBER OF REFLECTIONS : 66799 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 3298 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.59 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.63 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 3.13 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 221 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2970 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 213 REMARK 3 BIN R VALUE (WORKING SET) : 0.2950 REMARK 3 BIN FREE R VALUE : 0.3410 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.62 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 8 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5475 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 482 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.26860 REMARK 3 B22 (A**2) : 2.21840 REMARK 3 B33 (A**2) : -5.48700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.280 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.148 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.133 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.142 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.131 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.918 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.894 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5639 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7625 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2011 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 142 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 800 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5639 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 736 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6830 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.30 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.66 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 9.5880 43.2559 4.7693 REMARK 3 T TENSOR REMARK 3 T11: -0.0189 T22: -0.0060 REMARK 3 T33: -0.1647 T12: 0.0181 REMARK 3 T13: -0.0066 T23: -0.0042 REMARK 3 L TENSOR REMARK 3 L11: 0.7299 L22: 0.4081 REMARK 3 L33: 0.7082 L12: -0.0113 REMARK 3 L13: -0.0488 L23: -0.0893 REMARK 3 S TENSOR REMARK 3 S11: -0.0134 S12: -0.0106 S13: 0.0052 REMARK 3 S21: -0.0210 S22: -0.0229 S23: 0.0110 REMARK 3 S31: -0.0088 S32: -0.0695 S33: 0.0364 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 30.3765 26.5976 37.7598 REMARK 3 T TENSOR REMARK 3 T11: -0.0294 T22: -0.0621 REMARK 3 T33: -0.1817 T12: 0.0173 REMARK 3 T13: -0.0089 T23: 0.0064 REMARK 3 L TENSOR REMARK 3 L11: 0.3532 L22: 0.5203 REMARK 3 L33: 2.5993 L12: 0.2763 REMARK 3 L13: -0.2008 L23: -0.8246 REMARK 3 S TENSOR REMARK 3 S11: -0.0136 S12: 0.0047 S13: -0.0297 REMARK 3 S21: 0.0883 S22: 0.0582 S23: 0.0370 REMARK 3 S31: -0.1590 S32: -0.1263 S33: -0.0446 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7AAC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1292111072. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 66837 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.590 REMARK 200 RESOLUTION RANGE LOW (A) : 81.015 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.12200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.59 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.79900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: INTERNAL MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5 M AMMONIUM SULFATE, 0.1 M TRIS PH REMARK 280 8.5, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.10750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.01450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.81450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.01450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.10750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.81450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 660 REMARK 465 SER A 661 REMARK 465 GLY B 660 REMARK 465 SER B 661 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 662 CG CD CE NZ REMARK 470 LYS A 664 CG CD CE NZ REMARK 470 GLN A 728 CG CD OE1 NE2 REMARK 470 GLU A 809 CG CD OE1 OE2 REMARK 470 LYS B 852 CG CD CE NZ REMARK 470 GLN B 853 CG CD OE1 NE2 REMARK 470 ASP B 914 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 914 71.55 -153.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1474 DISTANCE = 6.12 ANGSTROMS REMARK 525 HOH A1475 DISTANCE = 6.50 ANGSTROMS REMARK 525 HOH B1407 DISTANCE = 6.55 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 78P A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 78P B 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 1102 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7AAA RELATED DB: PDB REMARK 900 7AAA IS THE UNLIGANDED PROTEIN REMARK 900 RELATED ID: 7AAB RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH A DIFFERENT INHIBITOR. DESCRIBED IN REMARK 900 THE SAME PUBLICATION. REMARK 900 RELATED ID: 7AAD RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH A DIFFERENT INHIBITOR. DESCRIBED IN REMARK 900 THE SAME PUBLICATION. DBREF 7AAC A 662 1011 UNP P09874 PARP1_HUMAN 662 1011 DBREF 7AAC B 662 1011 UNP P09874 PARP1_HUMAN 662 1011 SEQADV 7AAC GLY A 660 UNP P09874 EXPRESSION TAG SEQADV 7AAC SER A 661 UNP P09874 EXPRESSION TAG SEQADV 7AAC ALA A 762 UNP P09874 VAL 762 ENGINEERED MUTATION SEQADV 7AAC GLY B 660 UNP P09874 EXPRESSION TAG SEQADV 7AAC SER B 661 UNP P09874 EXPRESSION TAG SEQADV 7AAC ALA B 762 UNP P09874 VAL 762 ENGINEERED MUTATION SEQRES 1 A 352 GLY SER LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU SEQRES 2 A 352 ILE LYS MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA SEQRES 3 A 352 MET VAL GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU SEQRES 4 A 352 GLY LYS LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER SEQRES 5 A 352 ILE LEU SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SEQRES 6 A 352 SER ASP SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR SEQRES 7 A 352 THR LEU ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO SEQRES 8 A 352 LEU LEU ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU SEQRES 9 A 352 MET LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER SEQRES 10 A 352 LEU LEU ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO SEQRES 11 A 352 ILE ASP VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS SEQRES 12 A 352 VAL VAL ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG SEQRES 13 A 352 LYS TYR VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA SEQRES 14 A 352 TYR ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG SEQRES 15 A 352 GLU GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU SEQRES 16 A 352 HIS ASN ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR SEQRES 17 A 352 ASN PHE ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA SEQRES 18 A 352 PRO PRO GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS SEQRES 19 A 352 GLY ILE TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN SEQRES 20 A 352 TYR CYS HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE SEQRES 21 A 352 LEU LEU GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU SEQRES 22 A 352 LYS HIS ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS SEQRES 23 A 352 HIS SER VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SEQRES 24 A 352 SER ALA ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU SEQRES 25 A 352 GLY THR GLY ILE SER SER GLY VAL ASN ASP THR SER LEU SEQRES 26 A 352 LEU TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL SEQRES 27 A 352 ASN LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS SEQRES 28 A 352 THR SEQRES 1 B 352 GLY SER LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU SEQRES 2 B 352 ILE LYS MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA SEQRES 3 B 352 MET VAL GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU SEQRES 4 B 352 GLY LYS LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER SEQRES 5 B 352 ILE LEU SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SEQRES 6 B 352 SER ASP SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR SEQRES 7 B 352 THR LEU ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO SEQRES 8 B 352 LEU LEU ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU SEQRES 9 B 352 MET LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER SEQRES 10 B 352 LEU LEU ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO SEQRES 11 B 352 ILE ASP VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS SEQRES 12 B 352 VAL VAL ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG SEQRES 13 B 352 LYS TYR VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA SEQRES 14 B 352 TYR ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG SEQRES 15 B 352 GLU GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU SEQRES 16 B 352 HIS ASN ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR SEQRES 17 B 352 ASN PHE ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA SEQRES 18 B 352 PRO PRO GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS SEQRES 19 B 352 GLY ILE TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN SEQRES 20 B 352 TYR CYS HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE SEQRES 21 B 352 LEU LEU GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU SEQRES 22 B 352 LYS HIS ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS SEQRES 23 B 352 HIS SER VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SEQRES 24 B 352 SER ALA ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU SEQRES 25 B 352 GLY THR GLY ILE SER SER GLY VAL ASN ASP THR SER LEU SEQRES 26 B 352 LEU TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL SEQRES 27 B 352 ASN LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS SEQRES 28 B 352 THR HET 78P A1101 18 HET SO4 A1102 5 HET 78P B1101 18 HET SO4 B1102 5 HETNAM 78P (2R)-2-(7-CARBAMOYL-1H-BENZIMIDAZOL-2-YL)-2- HETNAM 2 78P METHYLPYRROLIDINIUM HETNAM SO4 SULFATE ION HETSYN 78P VELIPARIB FORMUL 3 78P 2(C13 H16 N4 O) FORMUL 4 SO4 2(O4 S 2-) FORMUL 7 HOH *482(H2 O) HELIX 1 AA1 PRO A 666 PHE A 677 1 12 HELIX 2 AA2 ASP A 678 TYR A 689 1 12 HELIX 3 AA3 PRO A 697 LEU A 701 5 5 HELIX 4 AA4 SER A 702 GLN A 722 1 21 HELIX 5 AA5 SER A 725 ILE A 740 1 16 HELIX 6 AA6 ASN A 754 GLY A 780 1 27 HELIX 7 AA7 ASP A 788 LEU A 797 1 10 HELIX 8 AA8 SER A 808 THR A 821 1 14 HELIX 9 AA9 ALA A 823 ASN A 827 5 5 HELIX 10 AB1 GLY A 843 LYS A 849 1 7 HELIX 11 AB2 PRO A 850 LYS A 852 5 3 HELIX 12 AB3 ARG A 865 THR A 867 5 3 HELIX 13 AB4 ASN A 868 GLY A 876 1 9 HELIX 14 AB5 PRO A 885 TYR A 889 5 5 HELIX 15 AB6 MET A 900 TYR A 907 1 8 HELIX 16 AB7 PRO A 958 ASN A 961 5 4 HELIX 17 AB8 ASP A 993 ALA A 995 5 3 HELIX 18 AB9 PRO B 666 PHE B 677 1 12 HELIX 19 AC1 ASP B 678 TYR B 689 1 12 HELIX 20 AC2 PRO B 697 LEU B 701 5 5 HELIX 21 AC3 SER B 702 GLY B 723 1 22 HELIX 22 AC4 SER B 725 ILE B 740 1 16 HELIX 23 AC5 ASN B 754 GLY B 780 1 27 HELIX 24 AC6 ASP B 788 LEU B 797 1 10 HELIX 25 AC7 SER B 808 THR B 821 1 14 HELIX 26 AC8 ALA B 823 ASN B 827 5 5 HELIX 27 AC9 GLY B 843 LYS B 849 1 7 HELIX 28 AD1 PRO B 850 LYS B 852 5 3 HELIX 29 AD2 ARG B 865 THR B 867 5 3 HELIX 30 AD3 ASN B 868 GLY B 876 1 9 HELIX 31 AD4 PRO B 885 TYR B 889 5 5 HELIX 32 AD5 MET B 900 TYR B 907 1 8 HELIX 33 AD6 PRO B 958 ASN B 961 5 4 HELIX 34 AD7 ASP B 993 ALA B 995 5 3 SHEET 1 AA1 5 THR A 799 VAL A 803 0 SHEET 2 AA1 5 TYR A 829 ARG A 841 -1 O LYS A 838 N LYS A 802 SHEET 3 AA1 5 VAL A 997 PHE A1009 -1 O LYS A1004 N ILE A 834 SHEET 4 AA1 5 ILE A 916 ALA A 925 -1 N ILE A 919 O LEU A1003 SHEET 5 AA1 5 ARG A 857 SER A 864 -1 N ARG A 858 O VAL A 924 SHEET 1 AA2 4 ILE A 895 PHE A 897 0 SHEET 2 AA2 4 GLU A 988 VAL A 991 -1 O VAL A 991 N ILE A 895 SHEET 3 AA2 4 SER A 947 GLY A 950 -1 N GLY A 950 O GLU A 988 SHEET 4 AA2 4 MET A 929 LEU A 932 1 N TYR A 930 O SER A 947 SHEET 1 AA3 3 GLY A 974 SER A 976 0 SHEET 2 AA3 3 GLY A 952 PRO A 956 -1 N THR A 955 O ILE A 975 SHEET 3 AA3 3 LEU A 984 TYR A 986 1 O LEU A 985 N THR A 954 SHEET 1 AA4 2 ILE A 962 LEU A 964 0 SHEET 2 AA4 2 VAL A 967 VAL A 969 -1 O VAL A 969 N ILE A 962 SHEET 1 AA5 5 THR B 799 VAL B 803 0 SHEET 2 AA5 5 TYR B 829 ARG B 841 -1 O LYS B 838 N LYS B 802 SHEET 3 AA5 5 VAL B 997 PHE B1009 -1 O LEU B1002 N PHE B 837 SHEET 4 AA5 5 ILE B 916 ALA B 925 -1 N ILE B 919 O LEU B1003 SHEET 5 AA5 5 ARG B 857 SER B 864 -1 N ARG B 858 O VAL B 924 SHEET 1 AA6 4 ILE B 895 PHE B 897 0 SHEET 2 AA6 4 GLU B 988 VAL B 991 -1 O VAL B 991 N ILE B 895 SHEET 3 AA6 4 SER B 947 GLY B 950 -1 N GLY B 950 O GLU B 988 SHEET 4 AA6 4 MET B 929 LEU B 932 1 N TYR B 930 O SER B 947 SHEET 1 AA7 3 GLY B 974 SER B 976 0 SHEET 2 AA7 3 GLY B 952 PRO B 956 -1 N THR B 955 O ILE B 975 SHEET 3 AA7 3 LEU B 984 TYR B 986 1 O LEU B 985 N THR B 954 SHEET 1 AA8 2 ILE B 962 LEU B 964 0 SHEET 2 AA8 2 VAL B 967 VAL B 969 -1 O VAL B 969 N ILE B 962 SITE 1 AC1 10 HIS A 862 GLY A 863 TYR A 896 PHE A 897 SITE 2 AC1 10 SER A 904 TYR A 907 GLU A 988 HOH A1257 SITE 3 AC1 10 HOH A1359 HOH A1454 SITE 1 AC2 8 LYS A 903 LEU A 984 LEU A 985 TYR A 986 SITE 2 AC2 8 HOH A1205 HOH A1254 HOH A1304 HOH B1250 SITE 1 AC3 9 GLU B 763 HIS B 862 GLY B 863 TYR B 896 SITE 2 AC3 9 PHE B 897 SER B 904 TYR B 907 GLU B 988 SITE 3 AC3 9 HOH B1210 SITE 1 AC4 9 GLN A 722 HOH A1225 LYS B 903 LEU B 984 SITE 2 AC4 9 LEU B 985 TYR B 986 HOH B1202 HOH B1248 SITE 3 AC4 9 HOH B1251 CRYST1 48.215 91.629 162.029 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020740 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010914 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006172 0.00000